Portfolio Philosophies

All American Capital is able to achieve exceptionally high rates of return, fast portfolio turnaround times, and greater diversification by applying a variety of innovative methods in the following areas:

1. aggressive, honed searches for the best ventures,

2. deal structures that provide multiple tangible safeguards,

3. greater portfolio diversification by not needing to devote excessive capital to any particular venture,

4. placement of executives in each venture who have successful Wall Street experience,

5. mechanisms to promote profoundly the likelihood and speed of going public, and

6. active involvement in each venture to foster going public and/or being acquired successfully.

Unlike many venture capital firms wherein the managers wait for friends to bring them deals (and then make compromises on quality due to a limited deal selection), we actively and focally solicit venture opportunities.  We participate in trade associations and proactively contact the most prolific scientists and entrepreneurs in high-profit niches.  We participate with networks of prominent leaders in pharmaceutical, financial, medical, and other industries.

To make an intelligent decision about the commercial viability and risks of each venture, a specialized expert in the applicable industry niche is typically consulted.  Examples include sub-specialist physician researchers; prolific engineers who are active in the relevant field; and successful, street-savvy marketers.

We generally hold controlling interest in each venture in which we make a substantial investment.

Our management team has maintained successful performance records in a wide variety of industries.  Our intensive and broad experiences enable us to foster businesses in the full spectrum of phases: seed, early stage, late stage, and turnarounds.  The primary characteristic that we seek is a reasonable capacity for going public within twelve to eighteen months before any substantial investment is made.  Due to the explosive profit opportunities and often rapid turnarounds and because we seek commercially viable businesses in pharmaceuticals, medical devices, and pathology, applied biomedical businesses are expected to comprise the majority of our invested funds, but we are open to honorable businesses of any industry that can provide relatively rapid exit strategies, relatively low risk, and extremely high profit margins.

800-405-8111

Copyright 2007 All American Capital Corp.